Integration of signaling pathway and bromodomain and extra-terminal domain inhibition for the treatment of mutant Kirsten rat sarcoma viral oncogene homolog cancer

Mutant Kirsten rat sarcoma viral oncogene homolog (KRAS) is now a drugable oncogenic driver and the KRAS G12C variant responds clinically to sotorasib and adagrasib that covalently block the cysteine of the active center and inhibit downstream signaling and proliferation. Unfortunately, progression-...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Gerhard Hamilton, Sandra Stickler, Barbara Rath
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Open Exploration Publishing Inc. 2023-10-01
coleção:	Exploration of Targeted Anti-tumor Therapy
Assuntos:	non-small cell lung cancer kirsten rat sarcoma viral oncogene homolog son of sevenless 1 bromodomain and extra-terminal inhibitors proteolysis-targeting chimeras
Acesso em linha:	https://www.explorationpub.com/Journals/etat/Article/1002178
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!